glp-1 hfpef Mechanisms of Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit SGLT2i + GLP-1 RA: A

Diabetes 67(Supplement 1):522 Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P et al (2019) Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Antidepressants are the most commonly used treatment for clinical depression

The widespread use of GLP-1 therapies, particularly in obesity, has raised questions about appropriate prescribing, long-term safety, and equitable access

9.8%, OR = 1.6, 95% CI = 1.22.0) ( Importantly, our study assessed and compared the signal strength of the GLP-1 RA-related psychiatric AEs across different GLP-1 RA therapies

Glutaminase isoenzymes in the metabolic therapy of cancer

Why Nuwhite still stands out in the beauty and wellness space In a market filled with beauty supplements and quick glow promises, Nuwhite continues to hold attention for a reason